82_FR_39078 82 FR 38921 - National Cancer Institute; Notice of Closed Meetings

82 FR 38921 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 157 (August 16, 2017)

Page Range38921-38922
FR Document2017-17279

Federal Register, Volume 82 Issue 157 (Wednesday, August 16, 2017) 
[Federal Register Volume 82, Number 157 (Wednesday, August 16, 2017)]
[Notices]
[Pages 38921-38922]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-17279]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational R21 and Omnibus R03: SEP 3.
    Date: September 25-26, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Arlington Gateway, 801 N. Glebe Road, 
Arlington, VA 22203.
    Contact Person: Robert Stephen Coyne, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-5120, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R25 Education.
    Date: September 27, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program, Review Branch Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD, 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Program Project I.
    Date: October 12-13, 2017.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5007, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SBIR Phase II Bridge Awards.
    Date: October 12, 2017.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Program Project II (P01).
    Date: October 17-18, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville 1750 Rockville Pike 
Rockville, MD 20852.
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W122, Bethesda, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Program Project III (P01).
    Date: October 17-18, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Bethesda, MD 20892-9750, 240-276-6611, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Provocative Questions: SEP 4.
    Date: October 20, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational R21 and Omnibus R03: SEP-1.
    Date: October 25-26, 2017.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W238, Bethesda, MD 20892-9750 240-276-7755 [email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group, NCI Clinical and Translational R21 and Omnibus R03: SEP-4.
    Date: October 25-26, 2017.
    Time: 6:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20892-9750.
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R01 Review Teleconference.
    Date: October 31, 2017.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer

[[Page 38922]]

Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 10, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17279 Filed 8-15-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 157 / Wednesday, August 16, 2017 / Notices 38921 Contact Person: Najma S. Begum, Ph.D., 7W608, Rockville, MD 20850 (Telephone Name of Committee: National Cancer Scientific Review Officer, Review Branch, Conference Call). Institute Special Emphasis Panel, Provocative DEA, NIDDK, National Institutes of Health, Contact Person: Robert E. Bird, Ph.D., Questions: SEP 4. Room 7349, 6707 Democracy Boulevard, Scientific Review Officer, Research Program, Date: October 20, 2017. Bethesda, MD 20892–5452, (301) 594–8894, Review Branch Division of Extramural Time: 8:00 a.m. to 5:00 p.m. begumn@niddk.nih.gov. Activities, National Cancer Institute, NIH, Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance 9609 Medical Center Drive, Room 7W608, applications. Program Nos. 93.847, Diabetes, Bethesda, MD, 20892–9750, 240–276–6344, Place: Bethesda North Marriott Hotel & Endocrinology and Metabolic Research; birdr@mail.nih.gov. Conference Center, 5701 Marinelli Road, 93.848, Digestive Diseases and Nutrition Name of Committee: National Cancer Bethesda, MD 20852. Research; 93.849, Kidney Diseases, Urology Institute Special Emphasis Panel, NCI Contact Person: Hasan Siddiqui, Ph.D., and Hematology Research, National Institutes Program Project I. Scientific Review Officer, Special Review of Health, HHS) Date: October 12–13, 2017. Branch, Division of Extramural Activities, Time: 8:00 a.m. to 2:00 p.m. National Cancer Institute, NIH, 9609 Medical Dated: August 10, 2017. Agenda: To review and evaluate grant Center Drive, Room 7W240, Bethesda, MD David Clary, applications. 20892–9750, 240–276–5122, hasan.siddiqui@ Program Analyst, Office of Federal Advisory Place: Gaithersburg Marriott nih.gov. Committee Policy. Washingtonian Center, 9751 Washingtonian Name of Committee: National Cancer [FR Doc. 2017–17280 Filed 8–15–17; 8:45 am] Boulevard, Gaithersburg, MD 20878. Institute Special Emphasis Panel, NCI Contact Person: Anita T. Tandle, Ph.D., Clinical and Translational R21 and Omnibus BILLING CODE 4140–01–P Scientific Review Officer, Research Program R03: SEP–1. Review Branch, Division of Extramural Date: October 25–26, 2017. Activities, National Cancer Institute, NIH, Time: 8:00 a.m. to 2:00 p.m. DEPARTMENT OF HEALTH AND 9609 Medical Center Drive, Room 7W248, Agenda: To review and evaluate grant HUMAN SERVICES Bethesda, MD 20892–9750, 240–276–5007, applications. tandlea@mail.nih.gov. Place: Bethesda Marriott Suites, 6711 National Institutes of Health Name of Committee: National Cancer Democracy Boulevard, Bethesda, MD 20817. Institute Special Emphasis Panel, SBIR Phase Contact Person: Byeong-Chel Lee, Ph.D., National Cancer Institute; Notice of II Bridge Awards. Scientific Review Officer Resources and Closed Meetings Date: October 12, 2017. Training Review Branch, Division of Time: 10:00 a.m. to 5:00 p.m. Extramural Activities, National Cancer Pursuant to section 10(d) of the Agenda: To review and evaluate grant Institute, NIH, 9609 Medical Center Drive, Federal Advisory Committee Act, as applications. Room 7W238, Bethesda, MD 20892–9750 amended, notice is hereby given of the Place: National Cancer Institute Shady 240–276–7755 byeong-chel.lee@nih.gov. following meetings. Grove, 9609 Medical Center Drive, Room Name of Committee: National Cancer The meetings will be closed to the 7W238, Rockville, MD 20850, (Telephone Institute Initial Review Group, NCI Clinical public in accordance with the Conference Call). Contact Person: Jeffrey E. DeClue Ph.D., and Translational R21 and Omnibus R03: provisions set forth in sections SEP–4. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Research Technology and Contract Review Branch, Date: October 25–26, 2017. as amended. The grant applications and Division of Extramural Activities, National Time: 6:00 p.m. to 5:00 p.m. the discussions could disclose Cancer Institute, NIH, 9609 Medical Center Agenda: To review and evaluate grant confidential trade secrets or commercial Drive, Room 7W238, Bethesda, MD 20892– applications. property such as patentable material, 9750, 240–276–6371, decluej@mail.nih.gov. Place: Bethesda North Marriott Hotel & and personal information concerning Conference Center, 5701 Marinelli Road, Name of Committee: National Cancer Bethesda, MD 20892–9750. individuals associated with the grant Institute Special Emphasis Panel, NCI Contact Person: Eduardo E. Chufan, Ph.D., applications, the disclosure of which Program Project II (P01). Scientific Review Officer, Research would constitute a clearly unwarranted Date: October 17–18, 2017. Technology and Contract Review Branch, invasion of personal privacy. Time: 8:00 a.m. to 5:00 p.m. Division of Extramural Activities, National Agenda: To review and evaluate grant Name of Committee: National Cancer Cancer Institute, NIH, 9609 Medical Center applications. Institute Special Emphasis Panel, NCI Drive, Room 7W254, Bethesda, MD 20892– Place: Hilton Washington/Rockville 1750 Clinical and Translational R21 and Omnibus 9750, 240–276–7975, chufanee@mail.nih.gov. Rockville Pike Rockville, MD 20852. R03: SEP 3. Contact Person: Sanita Bharti, Ph.D., Name of Committee: National Cancer Date: September 25–26, 2017. Scientific Review Officer, Research Program Institute Special Emphasis Panel, R01 Time: 8:00 a.m. to 5:30 p.m. Review Branch, Division of Extramural Review Teleconference. Agenda: To review and evaluate grant Activities, National Cancer Institute, NIH, Date: October 31, 2017. applications. 9609 Medical Center Drive, Room 7W122, Time: 1:00 p.m. to 5:00 p.m. Place: The Westin Arlington Gateway, 801 Bethesda, MD 20892–9750, 240–276–5909, Agenda: To review and evaluate grant N. Glebe Road, Arlington, VA 22203. sanitab@mail.nih.gov. applications. Contact Person: Robert Stephen Coyne, Name of Committee: National Cancer Place: National Cancer Institute Shady Ph.D., Scientific Review Officer, Research Institute Special Emphasis Panel, NCI Grove, 9609 Medical Center Drive, Room Program Review Branch, Division of Program Project III (P01). 7W608, Rockville, MD 20850, (Telephone Extramural Activities, National Cancer Date: October 17–18, 2017. Conference Call). Institute, NIH, 9609 Medical Center Drive, Time: 8:00 a.m. to 12:00 p.m. Contact Person: Robert E. Bird, Ph.D., Room 7W236, Bethesda, MD 20892–9750, Agenda: To review and evaluate grant Scientific Review Officer, Research Program 240–276–5120, coynes@mail.nih.gov. Review Branch, Division of Extramural asabaliauskas on DSKBBXCHB2PROD with NOTICES applications. Name of Committee: National Cancer Place: Hilton Washington/Rockville, 1750 Activities, National Cancer Institute, NIH, Institute Special Emphasis Panel, R25 Rockville Pike, Rockville, MD 20852. 9609 Medical Center Drive, Room 7W608, Education. Contact Person: Mukesh Kumar, Ph.D., Bethesda, MD 20892–9750, 240–276–6344, Date: September 27, 2017. Scientific Review Officer, Research Program birdr@mail.nih.gov. Time: 1:00 p.m. to 4:00 p.m. Review Branch, Division of Extramural (Catalogue of Federal Domestic Assistance Agenda: To review and evaluate grant Activities, National Cancer Institute, NIH, Program Nos. 93.392, Cancer Construction; applications. 9609 Medical Center Drive, Room 7W618, 93.393, Cancer Cause and Prevention Place: National Cancer Institute Shady Bethesda, MD 20892–9750, 240–276–6611, Research; 93.394, Cancer Detection and Grove, 9609 Medical Center Drive, Room sanitab@mail.nih.gov. Diagnosis Research; 93.395, Cancer VerDate Sep<11>2014 18:33 Aug 15, 2017 Jkt 241001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1

38922 Federal Register / Vol. 82, No. 157 / Wednesday, August 16, 2017 / Notices Treatment Research; 93.396, Cancer Biology interested in making oral presentations the 21st Century Cures Act, and 5 (five) Research; 93.397, Cancer Centers Support; are encouraged to notify the DFO on or years after such date of enactment, the 93.398, Cancer Research Manpower; 93.399, before August 24, 2017. Two minutes ISMICC shall submit a report to Cancer Control, National Institutes of Health, will be allotted for each presentation. Congress and any other relevant federal HHS) Substantive meeting information and department or agency. Dated: August 10, 2017. a roster of Committee members is Melanie J. Pantoja, available at the Committee’s Web site II. Structure, Membership, and Program Analyst, Office of Federal Advisory https://www.samhsa.gov/about-us/ Operation Committee Policy. advisory-councils/smi-committee or by [FR Doc. 2017–17279 Filed 8–15–17; 8:45 am] contacting Pamela Foote, DFO. This ISMICC consists of federal Committee Name: Interdepartmental members listed below or their BILLING CODE 4140–01–P Serious Mental Illness Coordinating designees, and non-federal public Committee members. DEPARTMENT OF HEALTH AND Dates/Time/Type: August 31, 2017/ Federal Membership: The ISMICC HUMAN SERVICES 9:00 a.m.—5:00 p.m./OPEN will be composed of the following Place: Hubert H. Humphrey Building, federal members or their designees: The Substance Abuse and Mental Health 200 Independence Avenue SW., Room Secretary of HHS; The Assistant Services Administration 800, Washington, DC 20201. Webcast Secretary for Mental Health and and teleconference (see information Notice of Meeting for the Substance Use; The Attorney General; above). Interdepartmental Serious Mental DFO: Pamela Foote, Substance Abuse The Secretary of the Department of Illness Coordinating Committee and Mental Health Services Veterans Affairs; The Secretary of the Administration, 5600 Fishers Lane, Department of Defense; The Secretary of AGENCY: Substance Abuse and Mental the Department of Housing and Urban Health Services Administration, HHS. 14E53C, Rockville, MD 20857; telephone: 240–276–1279; email: Development; The Secretary of the ACTION: Notice. Department of Education; The Secretary pamela.foote@samhsa.hhs.gov SUMMARY: The Secretary of Health and SUPPLEMENTARY INFORMATION: of the Department of Labor; The Human Services (Secretary), in Administrator of the Centers for I. Background and Authority Medicare and Medicaid Services; and accordance with section 6031 of the 21st Century Cures Act, announces the The ISMICC was established on The Commissioner of the Social inaugural meeting of the March 15, 2017, in accordance with Security Administration. Interdepartmental Serious Mental section 6031 of the 21st Century Cures Non-federal Membership: The ISMICC Illness Coordinating Committee Act, and the Federal Advisory includes 14 non-federal public members (ISMICC). The ISMICC will meet on Committee Act, 5 U.S.C. App., as appointed by the Secretary representing, August 31, 2017, from 9:00 a.m. to 5:00 amended, to report to the Secretary, psychologists, psychiatrists, social p.m., Eastern Time. The meeting will be Congress, and any other relevant federal workers, peer support specialists, and held at the Hubert H. Humphrey department or agency on advances in other providers, patients, family of Building, 200 Independence Avenue serious mental illness (SMI) and serious patients, law enforcement, the judiciary, SW., Room 800, Washington, DC 20201. emotional disturbance (SED), research and leading research, advocacy, or The meeting will include information related to the prevention of, diagnosis service organizations. A roster of on federal advances related to serious of, intervention in, and treatment and Committee members is available at the mental illness (SMI) and serious recovery of SMIs, SEDs, and advances in Committee’s Web site: https:// emotional disturbance (SED), including access to services and support for adults www.samhsa.gov/about-us/advisory- data evaluation, and recommendations with SMI or children with SED. In addition, the ISMICC will evaluate the councils/smi-committee. The term of for action. Committee members will also office of an ISMICC non-federal member discuss workgroups, future meetings, effect federal programs related to serious mental illness have on public health, is three years, and is subject to and the Report to Congress. including public health outcomes such reappointment to serve for one or more Members of the public can attend the meeting via telephone or webcast. The as (A) rates of suicide, suicide attempts, additional three-year terms. If a vacancy meeting can be accessed via webcast at incidence and prevalence of SMIs, occurs in the ISMICC among the www.hhs.gov/live. To obtain the call-in SEDs, and substance use disorders, members, the Secretary shall make an number and access code, submit written overdose, overdose deaths, emergency appointment to fill such vacancy within or brief oral comments, or request hospitalizations, emergency room 90 days from the date the vacancy special accommodations for persons boarding, preventable emergency room occurs. Any member appointed to fill a with disabilities, please register at the visits, interaction with the criminal vacancy for an unexpired term shall be SAMHSA Advisory Committees Web justice system, homelessness, and appointed for the remainder of such site at https://www.samhsa.gov/about- unemployment; (B) increased rates of term. A member may serve after the us/advisory-councils/smi-committee or employment and enrollment in expiration of the member’s term until a contact Pamela Foote, Designated educational and vocational programs; successor has been appointed. Initial Federal Official (see contact information (C) quality of mental and substance use appointments shall be made in such a manner as to ensure that the terms of asabaliauskas on DSKBBXCHB2PROD with NOTICES below). disorders treatment services; or (D) any Interested persons may present data, other criteria as may be determined by the members will not all expire in the information, or views, orally or in the Secretary. Finally, the ISMICC will same year. The ISMICC is required to writing, on issues pending before the make specific recommendations for meet twice per year. committee. Written statements should actions that agencies can take to better Carlos Castillo, be submitted to the DFO on or before coordinate the administration of mental August 24, 2017. Oral presentations health services for adults with SMI or Committee Management Officer. from the public will be scheduled at the children with SED. Not later than 1 [FR Doc. 2017–17187 Filed 8–15–17; 8:45 am] conclusion of the meeting. Individuals (one) year after the date of enactment of BILLING CODE 4162–20–P VerDate Sep<11>2014 18:33 Aug 15, 2017 Jkt 241001 PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\16AUN1.SGM 16AUN1


Document Created: 2017-08-16 10:27:20
Document Modified: 2017-08-16 10:27:20
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 25-26, 2017.
FR Citation82 FR 38921 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR